A population-based study of Coats disease in the United Kingdom II: Investigation, treatment, and outcomes

Eye

Volumn 24, Issue 12, 2010, Pages 1802-1807

  Mulvihill, A ^a   Morris, B ^a  

^a PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

Author keywords

Coats disease; laser photocoagulation; retinal exudation

Indexed keywords

VASCULOTROPIN INHIBITOR;

ARGON LASER; ARTICLE; CILIARY DISK; CRYOTHERAPY; DIODE LASER; EXUDATIVE RETINITIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; QUESTIONNAIRE; RETINA DETACHMENT; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRASOUND; VISUAL ACUITY; VITRECTOMY; YAG LASER;

EID: 78650213681     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.127     Document Type: Article

References (17)

1. Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: The 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 2001; 131(5): 561-571.
2. Cahill M, O'Keefe M, Acheson R, Mulvihill A, Wallace D, Mooney D. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation. Acta Ophthalmol Scand 2001; 79: 596-602.
3. Budning AS, Heon E, Gallie BL. Visual prognosis of Coats disease. J Am Assoc Pediatr Ophthalmol Strabismus 1998; 2: 356-359.
4. Coats G. Forms of retinal diseases with massive exudation. Roy London Ophthalmol Hosp Rep 1908; 17: 440-525.
5. Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: The 2000 Proctor Lecture. Am J Ophthalmol 2001; 131(5): 572-583.
6. Shields JA, Shields CL. Coats disease: The 2001 LuEsther T Mertz lecture. Retina 2002; 22(1): 80-91.
7. Shields JA, Shields CL. Differentiation of Coats disease and retinoblastoma. J Am Assoc Pediatr Ophthalmol Strabismus 2001; 38: 262-266.
8. Char DH. Coats' disease: Long term follow up. Br J Ophthalmol 2000; 84(1): 37-39.
9. Shields CL, Mashayekhi A, Luo CK, Materin JA, Shields JA. Optical coherence tomography in children: Analysis of 44 eyes with intraocular tumors and simulating conditions. J Pediatr Ophthalmol Strabismus 2004; 41(6): 338-344.
10. Adam RS, Kertes PJ, Lam WC. Observations on the management of Coats disease: Less is more. Br J Ophthalmol 2007; 91(3): 303-306.
11. Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF. Coats disease in adulthood. Ophthalmol 2005; 112(6): 1072-1078.
12. Schefler AC, Berrocal AM, Murray TG. Advanced Coats disease: Management with repetitive aggressive laser ablation therapy. Retina 2008; 28(3 suppl): S38-S41.
13. Mrejen S, Metge F, Denion E, Dureau P, Edelson C, Caputo G. Management of retinal detachment in Coats disease. Retina 2008; 28(3 suppl): S26-S32.
14. Jain SY, Moshfeghi DM. Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 2007; 245(9): 1387-1388.
15. Jun JH, Kim YC, Kim KS. Resolution of severe macular oedema in adults Coats disease with intravitreal triamcinolone and bevacizumab injection. Korean J Ophthalmol 2008; 22(3): 190-193.
16. Bergstrom CS, Hubbard GB. Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina 2008; 28(3 suppl): S33-S37.
17. Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol 2006; 141(4): 629-637.